Literature DB >> 7808489

Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

F Kirchhoff1, T C Greenough, D B Brettler, J L Sullivan, R C Desrosiers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7808489     DOI： 10.1056/NEJM199501263320405

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  402 in total

1.  Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation.

Authors:  H Akari; S Arold; T Fukumori; T Okazaki; K Strebel; A Adachi
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection.

Authors:  S I Staprans; P J Dailey; A Rosenthal; C Horton; R M Grant; N Lerche; M B Feinberg
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

3.  A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation.

Authors:  L Alexander; Z Du; M Rosenzweig; J U Jung; R C Desrosiers
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Disrupting surfaces of nef required for downregulation of CD4 and for enhancement of virion infectivity attenuates simian immunodeficiency virus replication in vivo.

Authors:  A J Iafrate; S Carl; S Bronson; C Stahl-Hennig; T Swigut; J Skowronski; F Kirchhoff
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

Authors:  Mohan Somasundaran; Mark Sharkey; Beda Brichacek; Katherine Luzuriaga; Michael Emerman; John L Sullivan; Mario Stevenson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

6.  Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child.

Authors:  Louis Alexander; Mary Janette Aquino-DeJesus; Michael Chan; Warren A Andiman
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Development and validation of a high-content bimolecular fluorescence complementation assay for small-molecule inhibitors of HIV-1 Nef dimerization.

Authors:  Jerrod A Poe; Laura Vollmer; Andreas Vogt; Thomas E Smithgall
Journal:  J Biomol Screen       Date:  2013-11-26

8.  Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells.

Authors:  Minoru Tobiume; Janet E Lineberger; Christopher A Lundquist; Michael D Miller; Christopher Aiken
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles.

Authors:  Michael Schindler; Stephanie Würfl; Philippe Benaroch; Thomas C Greenough; Rod Daniels; Philippa Easterbrook; Matthias Brenner; Jan Münch; Frank Kirchhoff
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression.

Authors:  N L Michael; G Chang; L A d'Arcy; C J Tseng; D L Birx; H W Sheppard
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.